Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNMT1 is associated with cell cycle and DNA replication gene sets in diffuse large B-cell lymphoma

12 Oct 2017

Abstract excerpt

Dysregulation of DNA (cytosine-5)-methyltransferase 1 (DNMT1) is associated with the pathogenesis of various types of cancer. It has been previously shown that DNMT1 is frequently expressed in diffuse large B-cell lymphoma (DLBCL), however its functions remain to be elucidated in the disease. In this study, we gene expression profiled (GEP) shRNA targeting DNMT1(shDNMT1)-treated germinal center B-cell-like DLBCL...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Treatments and Mutations
Share to Lymphoma Diagnosis and Treatment
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29137822
DOI: 10.1016/j.prp.2017.10.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNMT1 is associated with cell cycle and DNA replication gene sets in diffuse large B-cell lymphomaPMID 29137822Read ↗

DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B‐cell lymphomasSemantic proximity Read ↗

The EBV-Positive Tumor Methylome is Distinct from EBV-Negative in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patientsSemantic proximity Read ↗

The epigenetic basis of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Analysis of CCND3 mutations in diffuse large B-cell lymphomaSemantic proximity Read ↗

A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphomaSemantic proximity Read ↗

Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomasSemantic proximity Read ↗

DNA replication stress-induced transcriptome of Human Burkitt’s lymphoma identifies MBD1 as a novel suppressor of <i>BCL6</i> rearrangements in germinal center derived B-lymphomagenesisSemantic proximity Read ↗

Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere lengthSemantic proximity Read ↗

DNA methyltransferases in hematological malignancies.Semantic proximity Read ↗

DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphomaSemantic proximity Read ↗

Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.